NOS Clone 5D5-H7 Monoclonal Antibody
Anti-human inducible Nitric Oxide Synthase Monoclonal Antibody 5D5-H7
Reactivity
HumanCrossreactivity Note: No cross reaction with nNOS or eNOS Histochem and ICC staining
Applications
Western Blot
Synonyms
NOS Clone 5D5-H7; Monoclonal Antibody; Anti-human inducible Nitric Oxide Synthase Monoclonal Antibody 5D5-H7; anti-NOS Clone 5D5-H7 antibody
Reactivity
Human
Crossreactivity Note: No cross reaction with nNOS or eNOS Histochem and ICC staining
Crossreactivity Note: No cross reaction with nNOS or eNOS Histochem and ICC staining
Clonality
Monoclonal
Isotype
Mouse IgG1 kappa
Clone Number
5D5-H7
Specificity
Polypeptide ::: % Cross Reactivity
rhiNOS (Type II) ::: 100
rhiNOS (Type II) ::: 100
Form/Format
Supplied as the IgG Fraction from Ascites Fluid
Applicable Applications for anti-NOS Clone 5D5-H7 antibody
Western Blot, Immunofluorescent Staining
Application Notes
Western Blot: Western blots resulted in a single band being detected at ~ 130 kDa at a dilution of 250 ng/ml
Immunofluorescent: This IgG fraction of monoclonal antibody 5D5-H7 has been found to stain cells induced to produce iNOS using a dilution of 1.0 ug/ml. The ability of this monoclonal antibody to bind to iNOS in fixed cells was examined using three different cell lines. DLD-1 (a human colorectal carcinoma cell line). A-172 (a human glioblastoma cell line) and RAW 264.7 (a mouse macrophage cell line). The cells were cultured for 2 days in normal medium and then induced to produce iNOS by treatment for 16 hours with a cytokine/LPS mixture. Following the treatment. the cells were washed x 4 and fixed with neutral buffered formalin. They were reacted for 60 minutes with the primary antibody. and then with FITC-conjugated goat anti-mouse IgG. The immunofluorescent staining pattern was observed using epifluorescence microscopy. This IgG fraction has also been found to stain freshly fixed tissue and frozen sections by histochemical techniques
Immunofluorescent: This IgG fraction of monoclonal antibody 5D5-H7 has been found to stain cells induced to produce iNOS using a dilution of 1.0 ug/ml. The ability of this monoclonal antibody to bind to iNOS in fixed cells was examined using three different cell lines. DLD-1 (a human colorectal carcinoma cell line). A-172 (a human glioblastoma cell line) and RAW 264.7 (a mouse macrophage cell line). The cells were cultured for 2 days in normal medium and then induced to produce iNOS by treatment for 16 hours with a cytokine/LPS mixture. Following the treatment. the cells were washed x 4 and fixed with neutral buffered formalin. They were reacted for 60 minutes with the primary antibody. and then with FITC-conjugated goat anti-mouse IgG. The immunofluorescent staining pattern was observed using epifluorescence microscopy. This IgG fraction has also been found to stain freshly fixed tissue and frozen sections by histochemical techniques
Western Blot Protocol: 1. After SDS-PAGE on 7.5% gels and electrophoretic transfer to PVDF membrane. block the membrane overnight with 4% normal goat serum in TBS/Tween-20 buffer.
2. Wash x 2 with TBS/Tween-20.
3. Apply the mouse monoclonal antibody after preparing a 250 ng/ml solution. Use 2% normal goat serum in TBS/Tween-20 as buffer for the primary antibody. Let the primary antibody bind for 2-4 hours.
4. Wash x 3 with TBS/Tween-20.
5. Apply affinity purified HRP-goat anti-mouse IgG antiserum diluted 1:2500 (Note: dilution may vary depending upon supplier) in 2% normal goat serum in TBS/Tween-20. Incubate 1-2 hours. Greater sensitivity may be achieved using ABC techniques.
6. Wash x 5 for 5 min per cycle in TBS/Tween-20.
7. Develop color using the enhanced DAB reaction.
Immunofluorescent: This IgG fraction of monoclonal antibody 5D5-H7 has been found to stain cells induced to produce iNOS using a dilution of 1.0 ug/ml. The ability of this monoclonal antibody to bind to iNOS in fixed cells was examined using three different cell lines. DLD-1 (a human colorectal carcinoma cell line). A-172 (a human glioblastoma cell line) and RAW 264.7 (a mouse macrophage cell line). The cells were cultured for 2 days in normal medium and then induced to produce iNOS by treatment for 16 hours with a cytokine/LPS mixture. Following the treatment. the cells were washed x 4 and fixed with neutral buffered formalin. They were reacted for 60 minutes with the primary antibody. and then with FITC-conjugated goat anti-mouse IgG. The immunofluorescent staining pattern was observed using epifluorescence microscopy. This IgG fraction has also been found to stain freshly fixed tissue and frozen sections by histochemical techniques
Immunofluorescent: This IgG fraction of monoclonal antibody 5D5-H7 has been found to stain cells induced to produce iNOS using a dilution of 1.0 ug/ml. The ability of this monoclonal antibody to bind to iNOS in fixed cells was examined using three different cell lines. DLD-1 (a human colorectal carcinoma cell line). A-172 (a human glioblastoma cell line) and RAW 264.7 (a mouse macrophage cell line). The cells were cultured for 2 days in normal medium and then induced to produce iNOS by treatment for 16 hours with a cytokine/LPS mixture. Following the treatment. the cells were washed x 4 and fixed with neutral buffered formalin. They were reacted for 60 minutes with the primary antibody. and then with FITC-conjugated goat anti-mouse IgG. The immunofluorescent staining pattern was observed using epifluorescence microscopy. This IgG fraction has also been found to stain freshly fixed tissue and frozen sections by histochemical techniques
Western Blot Protocol: 1. After SDS-PAGE on 7.5% gels and electrophoretic transfer to PVDF membrane. block the membrane overnight with 4% normal goat serum in TBS/Tween-20 buffer.
2. Wash x 2 with TBS/Tween-20.
3. Apply the mouse monoclonal antibody after preparing a 250 ng/ml solution. Use 2% normal goat serum in TBS/Tween-20 as buffer for the primary antibody. Let the primary antibody bind for 2-4 hours.
4. Wash x 3 with TBS/Tween-20.
5. Apply affinity purified HRP-goat anti-mouse IgG antiserum diluted 1:2500 (Note: dilution may vary depending upon supplier) in 2% normal goat serum in TBS/Tween-20. Incubate 1-2 hours. Greater sensitivity may be achieved using ABC techniques.
6. Wash x 5 for 5 min per cycle in TBS/Tween-20.
7. Develop color using the enhanced DAB reaction.
Related Product Information for anti-NOS Clone 5D5-H7 antibody
This IgG Fraction was isolated from ascites fluid contains mouse monoclonal antibody 5D5-H7 raised against recombinant hiNOS. The 50 ?gm of purified IgG has been packaged in 100 ?l of 10 mg/ml BSA in PBS as carrier protein. This monoclonal antibody has been found to stain hiNOS in western immunoblots and by immunocytochemistry. This monoclonal antibody was tested for recognition of other NOS isoforms by ELISA. western blot. and immunocytochemical techniques. It has been found to be a mouse IgG1 kappa by isotyping
Product Categories/Family for anti-NOS Clone 5D5-H7 antibody
NCBI and Uniprot Product Information
NCBI GI #
NCBI Official Full Name
NOS
Similar Products
Product Notes
The NOS Clone 5D5-H7 (Catalog #AAA350059) is an Antibody and is intended for research purposes only. The product is available for immediate purchase. The Anti-human inducible Nitric Oxide Synthase Monoclonal Antibody 5D5-H7 reacts with Human Crossreactivity Note: No cross reaction with nNOS or eNOS Histochem and ICC staining and may cross-react with other species as described in the data sheet. AAA Biotech's NOS Clone 5D5-H7 can be used in a range of immunoassay formats including, but not limited to, Western Blot, Immunofluorescent Staining. Western Blot: Western blots resulted in a single band being detected at ~ 130 kDa at a dilution of 250 ng/ml Immunofluorescent: This IgG fraction of monoclonal antibody 5D5-H7 has been found to stain cells induced to produce iNOS using a dilution of 1.0 ug/ml. The ability of this monoclonal antibody to bind to iNOS in fixed cells was examined using three different cell lines. DLD-1 (a human colorectal carcinoma cell line). A-172 (a human glioblastoma cell line) and RAW 264.7 (a mouse macrophage cell line). The cells were cultured for 2 days in normal medium and then induced to produce iNOS by treatment for 16 hours with a cytokine/LPS mixture. Following the treatment. the cells were washed x 4 and fixed with neutral buffered formalin. They were reacted for 60 minutes with the primary antibody. and then with FITC-conjugated goat anti-mouse IgG. The immunofluorescent staining pattern was observed using epifluorescence microscopy. This IgG fraction has also been found to stain freshly fixed tissue and frozen sections by histochemical techniques Immunofluorescent: This IgG fraction of monoclonal antibody 5D5-H7 has been found to stain cells induced to produce iNOS using a dilution of 1.0 ug/ml. The ability of this monoclonal antibody to bind to iNOS in fixed cells was examined using three different cell lines. DLD-1 (a human colorectal carcinoma cell line). A-172 (a human glioblastoma cell line) and RAW 264.7 (a mouse macrophage cell line). The cells were cultured for 2 days in normal medium and then induced to produce iNOS by treatment for 16 hours with a cytokine/LPS mixture. Following the treatment. the cells were washed x 4 and fixed with neutral buffered formalin. They were reacted for 60 minutes with the primary antibody. and then with FITC-conjugated goat anti-mouse IgG. The immunofluorescent staining pattern was observed using epifluorescence microscopy. This IgG fraction has also been found to stain freshly fixed tissue and frozen sections by histochemical techniques Western Blot Protocol: 1. After SDS-PAGE on 7.5% gels and electrophoretic transfer to PVDF membrane. block the membrane overnight with 4% normal goat serum in TBS/Tween-20 buffer. 2. Wash x 2 with TBS/Tween-20. 3. Apply the mouse monoclonal antibody after preparing a 250 ng/ml solution. Use 2% normal goat serum in TBS/Tween-20 as buffer for the primary antibody. Let the primary antibody bind for 2-4 hours. 4. Wash x 3 with TBS/Tween-20. 5. Apply affinity purified HRP-goat anti-mouse IgG antiserum diluted 1:2500 (Note: dilution may vary depending upon supplier) in 2% normal goat serum in TBS/Tween-20. Incubate 1-2 hours. Greater sensitivity may be achieved using ABC techniques. 6. Wash x 5 for 5 min per cycle in TBS/Tween-20. 7. Develop color using the enhanced DAB reaction. Researchers should empirically determine the suitability of the NOS Clone 5D5-H7 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "NOS Clone 5D5-H7, Monoclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
